Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tapentadol after surgery in children younger than 2 years
2014-002259-24Phase 2Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tapentadol in postoperative pain, sponsored by Grünenthal GmbH. Primary endpoints: Pharmacokinetic evaluation based on serum concentrations of tapentadol and Tapentadol-O-glucuronide serum concentrations. Started Nov 2014; status: terminated.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2014-002259-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002259-24.